Impact of Preprocedural Left Ventricular Ejection Fraction on 1-Year Outcomes After MitraClip Implantation (from the ACCESS-EU Phase I, a Prospective, Multicenter, Nonrandomized Postapproval Study of the MitraClip Therapy in Europe)

American Journal of Cardiology

Volumn 118, Issue 6, 2016, Pages 873-880

  Schäfer, Ulrich ^a   Maisano, Francesco ^b   Butter, Christian ^c   Franzen, Olaf ^d   Baldus, Stephan ^e   Hausleiter, Jörg ^f   Ussia, Gian Paolo ^g   Sievert, Horst ^h   Geist, Volker ⁱ   Widder, Julian Daniel ^j   Moccetti, Tiziano ^k   Schillinger, Wolfgang ^l  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Heart Center Brandenburg   (Germany)

^d KLINIK IM PARK   (Switzerland)

^e UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g UNIVERSITY OF ROME TOR VERGATA   (Italy)

^h CARDIOVASCULAR CENTER FRANKFURT   (Germany)

ⁱ UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^j HANNOVER MEDICAL SCHOOL   (Germany)

^k DIVISION OF CARDIOLOGY   (Switzerland)

^l Helios Albert Schweitzer Hospital Northeim   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; DEVICE APPROVAL; DISEASE SEVERITY; EUROPE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTABLE CLIP; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE; MULTICENTER STUDY; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; QUESTIONNAIRE; SIX MINUTE WALK TEST; SURVIVAL RATE; TREATMENT OUTCOME; CASE CONTROL STUDY; CLINICAL TRIAL; HEART CATHETERIZATION; HEART STROKE VOLUME; HOSPITAL MORTALITY; KAPLAN MEIER METHOD; MIDDLE AGED; MITRAL ANNULOPLASTY; MITRAL VALVE INSUFFICIENCY; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS; REGISTER; SEVERITY OF ILLNESS INDEX; SURGICAL EQUIPMENT; VERY ELDERLY; WALK TEST;

AGED; AGED, 80 AND OVER; CARDIAC CATHETERIZATION; CASE-CONTROL STUDIES; FEMALE; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MITRAL VALVE ANNULOPLASTY; MITRAL VALVE INSUFFICIENCY; MORTALITY; PROGNOSIS; REGISTRIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SURGICAL INSTRUMENTS; TREATMENT OUTCOME; WALK TEST;

EID: 84994107991     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2016.06.036     Document Type: Article

References (26)

1. 1 Gaasch, W.H., Meyer, T.E., Left ventricular response to mitral regurgitation: implications for management. Circulation 118 (2008), 2298–2303.
2. 2 Robbins, J.D., Maniar, P.B., Cotts, W., Parker, M.A., Bonow, R.O., Gheorghiade, M., Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol 91 (2003), 360–362.
3. 3 Trichon, B.H., Felker, G.M., Shaw, L.K., Cabell, C.H., O'Connor, C.M., Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 91 (2003), 538–543.
4. 4 Bonow, R.O., Carabello, B.A., Chatterjee, K., de Leon, A.C. Jr., Faxon, D.P., Freed, M.D., Gaasch, W.H., Lytle, B.W., Nishimura, R.A., O'Gara, P.T., O'Rourke, R.A., Otto, C.M., Shah, P.M., Shanewise, J.S., 2006 Writing Committee Members; American College of Cardiology/American Heart Association Task Force. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118 (2008), e523–e661.
5. 5 Grigioni, F., Enriquez-Sarano, M., Zehr, K.J., Bailey, K.R., Tajik, A.J., Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103 (2001), 1759–1764.
6. 6 De Bonis, M., Lapenna, E., Verzini, A., La Canna, G., Grimaldi, A., Torracca, L., Maisano, F., Alfieri, O., Recurrence of mitral regurgitation parallels the absence of left ventricular reverse remodeling after mitral repair in advanced dilated cardiomyopathy. Ann Thorac Surg 85 (2008), 932–939.
7. 7 Bach, D.S., Bolling, S.F., Early improvement in congestive heart failure after correction of secondary mitral regurgitation in end-stage cardiomyopathy. Am Heart J 129 (1995), 1165–1170.
8. 8 Braun, J., Bax, J.J., Versteegh, M.I., Voigt, P.G., Holman, E.R., Klautz, R.J., Boersma, E., Dion, R.A., Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation. Eur J Cardiothorac Surg 27 (2005), 847–853.
9. 9 Crabtree, T.D., Bailey, M.S., Moon, M.R., Munfakh, N., Pasque, M.K., Lawton, J.S., Moazami, N., Aubuchon, K.A., Al-Dadah, A.S., Damiano, R.J. Jr., Recurrent mitral regurgitation and risk factors for early and late mortality after mitral valve repair for functional ischemic mitral regurgitation. Ann Thorac Surg 85 (2008), 1537–1542 discussion 1542–1543.
10. 10 De Bonis, M., Lapenna, E., La Canna, G., Ficarra, E., Pagliaro, M., Torracca, L., Maisano, F., Alfieri, O., Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy: role of the “edge-to-edge” technique. Circulation 112 (2005), I402–I408.
11. 11 McGee, E.C., Gillinov, A.M., Blackstone, E.H., Rajeswaran, J., Cohen, G., Najam, F., Shiota, T., Sabik, J.F., Lytle, B.W., McCarthy, P.M., Cosgrove, D.M., Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 128 (2004), 916–924.
12. 12 Magne, J., Senechal, M., Dumesnil, J.G., Pibarot, P., Ischemic mitral regurgitation: a complex multifaceted disease. Cardiology 112 (2009), 244–259.
13. 13 Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS), Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M.J., Baron-Esquivias, G., Baumgartner, H., Borger, M.A., Carrel, T.P., De Bonis, M., Evangelista, A., Falk, V., Iung, B., Lancellotti, P., Pierard, L., Price, S., Schafers, H.J., Schuler, G., Stepinska, J., Swedberg, K., Takkenberg, J., Von Oppell, U.O., Windecker, S., Zamorano, J.L., Zembala, M., Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33 (2012), 2451–2496.
14. 14 Taramasso, M., Maisano, F., Latib, A., Denti, P., Buzzatti, N., Cioni, M., La Canna, G., Colombo, A., Alfieri, O., Clinical outcomes of MitraClip for the treatment of functional mitral regurgitation. EuroIntervention 10 (2014), 746–752.
15. 15 Vakil, K., Roukoz, H., Sarraf, M., Krishnan, B., Reisman, M., Levy, W.C., Adabag, S., Safety and efficacy of the MitraClip® system for severe mitral regurgitation: a systematic review. Catheter Cardiovasc Interv 84 (2014), 129–136.
16. 16 Philip, F., Athappan, G., Tuzcu, E.M., Svensson, L.G., Kapadia, S.R., MitraClip for severe symptomatic mitral regurgitation in patients at high surgical risk: a comprehensive systematic review. Catheter Cardiovasc Interv 84 (2014), 581–590.
17. 17 Whitlow, P.L., Feldman, T., Pedersen, W.R., Lim, D.S., Kipperman, R., Smalling, R., Bajwa, T., Herrmann, H.C., Lasala, J., Maddux, J.T., Tuzcu, M., Kapadia, S., Trento, A., Siegel, R.J., Foster, E., Glower, D., Mauri, L., Kar, S., EVEREST II Investigators. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular valve edge-to-edge repair) high risk study. J Am Coll Cardiol 59 (2012), 130–139.
18. 18 Feldman, T., Foster, E., Glower, D.D., Kar, S., Rinaldi, M.J., Fail, P.S., Smalling, R.W., Siegel, R., Rose, G.A., Engeron, E., Loghin, C., Trento, A., Skipper, E.R., Fudge, T., Letsou, G.V., Massaro, J.M., Mauri, L., EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 364 (2011), 1395–1406.
19. 19 Silvestry, F.E., Rodriguez, L.L., Herrmann, H.C., Rohatgi, S., Weiss, S.J., Stewart, W.J., Homma, S., Goyal, N., Pulerwitz, T., Zunamon, A., Hamilton, A., Merlino, J., Martin, R., Krabill, K., Block, P.C., Whitlow, P., Tuzcu, E.M., Kapadia, S., Gray, W.A., Reisman, M., Wasserman, H., Schwartz, A., Foster, E., Feldman, T., Wiegers, S.E., Echocardiographic guidance and assessment of percutaneous repair for mitral regurgitation with the Evalve MitraClip: lessons learned from EVEREST I. J Am Soc Echocardiogr 20 (2007), 1131–1140.
20. 20 Goel, S.S., Bajaj, N., Aggarwal, B., Gupta, S., Poddar, K.L., Ige, M., Bdair, H., Anabtawi, A., Rahim, S., Whitlow, P.L., Tuzcu, E.M., Griffin, B.P., Stewart, W.J., Gillinov, M., Blackstone, E.H., Smedira, N.G., Oliveira, G.H., Barzilai, B., Menon, V., Kapadia, S.R., Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need. J Am Coll Cardiol 63 (2014), 185–186.
21. 21 Rossi, A., Dini, F.L., Faggiano, P., Agricola, E., Cicoira, M., Frattini, S., Simioniuc, A., Gullace, M., Ghio, S., Enriquez-Sarano, M., Temporelli, P.L., Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart 97 (2011), 1675–1680.
22. 22 Nishimura, R.A., Otto, C.M., Bonow, R.O., Carabello, B.A., Erwin, J.P. 3rd, Guyton, R.A., O'Gara, P.T., Ruiz, C.E., Skubas, N.J., Sorajja, P., Sundt, T.M. 3rd, Thomas, J.D., 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129 (2014), e521–e643.
23. 23 Iung, B., Baron, G., Butchart, E.G., Delahaye, F., Gohlke-Barwolf, C., Levang, O.W., Tornos, P., Vanoverschelde, J.L., Vermeer, F., Boersma, E., Ravaud, P., Vahanian, A., A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24 (2003), 1231–1243.
24. 24 Mirabel, M., Iung, B., Baron, G., Messika-Zeitoun, D., Detaint, D., Vanoverschelde, J.L., Butchart, E.G., Ravaud, P., Vahanian, A., What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?. Eur Heart J 28 (2007), 1358–1365.
25. 25 Taramasso, M., Maisano, F., Denti, P., Latib, A., La Canna, G., Colombo, A., Alfieri, O., Percutaneous edge-to-edge repair in high-risk and elderly patients with degenerative mitral regurgitation: midterm outcomes in a single-center experience. J Thorac Cardiovasc Surg 148 (2014), 2743–2750.
26. 26 Puls, M., Lubos, E., Boekstegers, P., von Bardeleben, R.S., Ouarrak, T., Butter, C., Zuern, C.S., Bekeredjian, R., Sievert, H., Nickenig, G., Eggebrecht, H., Senges, J., Schillinger, W., One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J 37 (2016), 703–712.